Blood thinners improve outcomes in 'moderately ill' Covid-19 patients
Treating Covid-19 patients who are not critically ill with blood thinning drugs helps reduce the need for organ support and critical care, a recently published study has found.
Treating Covid-19 patients who are not critically ill with blood thinning drugs helps reduce the need for organ support and critical care, a recently published study has found.
Patients, carers, service user groups and other stakeholders are being asked for their views on the proposal to move Imperial College Healthcare NHS Trust’s specialist infectious diseases inpatients service.
A new study of cells provides support and scientific validation for the MATIS clinical trial, led by Imperial College London and Imperial College Healthcare NHS Trust.
The north west London NHS has agreed to appoint a single chair for its four acute trusts.
A landmark report for a new national organ donation and transplantation plan in Greece has been accepted.